Skip to main content

Jupiter Neurosciences, Inc.

JUNS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001679628

No open-market purchases or sales by Jupiter Neurosciences, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $826.9K in total; no superinvestor holds it.

Politicians who traded JUNS

No member of Congress has reported a trade in Jupiter Neurosciences, Inc. shares or options since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report. Profiles, committees and photos: the unitedstates project (public domain). District maps: U.S. Census Bureau.